Stereotaxis, Inc.
Stereotaxis, Inc. (STXS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · STXS · as of Jun 9, 2026
Key Statistics
Explore Stereotaxis, Inc. Data
stxs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 100.0%
The STXS analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $3.50, representing +93.37% upside from the current price of $1.81.
Competitors & Peers
stxs competitorsSTXS
ARCT
CVRX
HUMA
MDXH
NEOStock Performance
Full HistoryAbout Stereotaxis, Inc.
Stereotaxis, Inc. specializes in the development, manufacturing, and commercialization of robotic systems, specialized instruments, and information management solutions for interventional laboratories…
what is stereotaxis, inc. · stxs stock overview · stereotaxis, inc. company profile · who is stereotaxis, inc. ceo · stxs AMEX · stereotaxis, inc. headquarters · stereotaxis, inc. business segments
About Stock Overview & Key Data
Stereotaxis, Inc. (STXS) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on AMEX since Aug 12, 2004. As of the latest trading session, STXS stock price is $1.81, with a market capitalization of $176.9M. The stock has returned -21.65% over the past 12 months and -21.30% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Stereotaxis, Inc. stock is Buy, with an average 12-month price target of $3.50. In fiscal year 2025, Stereotaxis, Inc. reported revenue of $32.4M and net income of -$21.6M. For detailed data — including Stereotaxis, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Stereotaxis, Inc. (STXS) stock price is $1.81. The stock is traded on AMEX under the ticker symbol STXS. The 52-week range is $1.70 – $3.59.